Advertisement

ADVERTISEMENT

Tom Valentino

News
Ibogaine Analog Reverses Effects of Stress in Mice
06/21/2021
A non-hallucinogenic analog of the psychedelic drug ibogaine has been found to rapidly reverse the effects of stress in mice, opening the door for a potential treatment of the detrimental impacts on the brain.
A non-hallucinogenic analog of the psychedelic drug ibogaine has been found to rapidly reverse the effects of stress in mice, opening the door for a potential treatment of the detrimental impacts on the brain.
A non-hallucinogenic analog of...
06/21/2021
Psych Congress Network
News
Monte Nido & Affiliates Adds 5th Brand to Portfolio
07/08/2021
The multi-state eating disorder treatment provider organization announced it is acquiring Waltham, Massachusetts-based Walden Behavioral Care, giving Monte Nido and Affiliates a network of more than 40 programs in 13 states.
The multi-state eating disorder treatment provider organization announced it is acquiring Waltham, Massachusetts-based Walden Behavioral Care, giving Monte Nido and Affiliates a network of more than 40 programs in 13 states.
The multi-state eating disorder...
07/08/2021
Behavioral Healthcare Executive
News
DEA Finalizes Measures to Ease Process for Providers to Add Mobile Components
06/29/2021
To expand access to medication-assisted treatment for opioid use disorder, particularly in rural areas with limited treatment options, DEA on Monday announced that it has published a final rule that allows registrants who are authorized to...
To expand access to medication-assisted treatment for opioid use disorder, particularly in rural areas with limited treatment options, DEA on Monday announced that it has published a final rule that allows registrants who are authorized to...
To expand access to...
06/29/2021
Behavioral Healthcare Executive
News
Psychedelics Briefs: Wesana Commits $1.5 Million to Support MAPS Research on MDMA-Assisted Therapy for TBI
09/15/2021
Wesana Health Holdings is committing an initial $1.5 million to assessing the viability of the Multidisciplinary Association for Psychedelics Studies’ (MAPS) MDMA-assisted therapy for the treatment of traumatic brain injuries. Lennham...
Wesana Health Holdings is committing an initial $1.5 million to assessing the viability of the Multidisciplinary Association for Psychedelics Studies’ (MAPS) MDMA-assisted therapy for the treatment of traumatic brain injuries. Lennham...
Wesana Health Holdings is...
09/15/2021
Behavioral Healthcare Executive
News
Stimulant Summit | Trauma-Informed Approach Key for Children Hurt by Parents’ Addiction
10/16/2021
In a presentation delivered Saturday during the Cocaine, Meth & Stimulant Summit, associate director Sarah VanDoren and victims services program coordinator Emily Hitchcock, LMHC, walked attendees through Cayuga Counseling Services’ Children...
In a presentation delivered Saturday during the Cocaine, Meth & Stimulant Summit, associate director Sarah VanDoren and victims services program coordinator Emily Hitchcock, LMHC, walked attendees through Cayuga Counseling Services’ Children...
In a presentation delivered...
10/16/2021
Addiction Professional
News
NCAD East | Long-Term Treatment More Closely Parallels Lifelong Recovery, but Short-Term Programs Have Practical Benefits, Too
11/21/2021
MARR Inc. Chief Clinical Officer Kimberly Alexander, MBA, LPC, CPCS, and CEO William Anderson Jr, LCSW, who presented at the National Conference on Addiction Disorders East on Sunday, share best practices for determining an appropriate level...
MARR Inc. Chief Clinical Officer Kimberly Alexander, MBA, LPC, CPCS, and CEO William Anderson Jr, LCSW, who presented at the National Conference on Addiction Disorders East on Sunday, share best practices for determining an appropriate level...
MARR Inc. Chief Clinical Officer...
11/21/2021
Addiction Professional
News
Psychedelics Briefs: Mindset Pharma, Otsuka Pharmaceutical, Novamind, Foundations for Change
01/05/2022
Otsuka Pharmaceutical’s McQuade Center for Strategic Research and Development (MSRD) has announced a collaboration with Mindset Pharma to support the development of psychedelic medicines.
Otsuka Pharmaceutical’s McQuade Center for Strategic Research and Development (MSRD) has announced a collaboration with Mindset Pharma to support the development of psychedelic medicines.
Otsuka Pharmaceutical’s McQuade...
01/05/2022
Behavioral Healthcare Executive
News
Business Briefs: US HealthVest, Evernorth, Recovery Centers of America
02/18/2022
US HealthVest has expanded Ridgeview Institute-Monroe Behavioral Hospital in Georgia. Evernorth, Cigna’s health services business division, is adding Monument Virtual alcohol use disorder treatment services. RCA is adding a program for...
US HealthVest has expanded Ridgeview Institute-Monroe Behavioral Hospital in Georgia. Evernorth, Cigna’s health services business division, is adding Monument Virtual alcohol use disorder treatment services. RCA is adding a program for...
US HealthVest has expanded...
02/18/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Revitalist, Alchemy Wellness, Diamond Therapeutics, Awakn Life Sciences
03/30/2022
Revitalist Lifestyle and Wellness has acquired Alchemy Wellness in Virginia, while Diamond Therapeutics has completed the last patient visit in its Phase I clinical trial studying low-dose psilocybin, and Awakn Life Sciences’ London clinic...
Revitalist Lifestyle and Wellness has acquired Alchemy Wellness in Virginia, while Diamond Therapeutics has completed the last patient visit in its Phase I clinical trial studying low-dose psilocybin, and Awakn Life Sciences’ London clinic...
Revitalist Lifestyle and...
03/30/2022
Behavioral Healthcare Executive
News
Business Briefs: Workit Health, Handspring Health, Landmark Recovery, Monument, Tempest
05/13/2022
Workit Health has launched a telehealth-based treatment program for stimulant use disorders, Handspring Health has closed a $6.2 million seed financing round, and Landmark Recovery has launched a second medication-assisted treatment clinic in...
Workit Health has launched a telehealth-based treatment program for stimulant use disorders, Handspring Health has closed a $6.2 million seed financing round, and Landmark Recovery has launched a second medication-assisted treatment clinic in...
Workit Health has launched a...
05/13/2022
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use